EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.1.1.267 | Bacterial Infections |
12937969 |
Fosmidomycin for the treatment of malaria. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 1.1.1.267 | Infections |
21724375 |
Resistance of the Burkholderia cepacia complex to fosmidomycin and fosmidomycin derivatives. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 1.1.1.267 | Malaria |
16289098 |
Reconstitution of an apicoplast-localised electron transfer pathway involved in the isoprenoid biosynthesis of Plasmodium falciparum. |
unassigned |
0 |
| 1.1.1.267 | Malaria |
17346161 |
Recent advances in antimalarial compounds and their patents. |
therapeutic application
unassigned |
1
0 |
| 1.1.1.267 | Malaria |
17690389 |
Molecular epidemiology of malaria in Cameroon. XXV. In vitro activity of fosmidomycin and its derivatives against fresh clinical isolates of Plasmodium falciparum and sequence analysis of 1-deoxy-D-xylulose 5-phosphate reductoisomerase. |
diagnostic usage
ongoing research
unassigned |
1
3
0 |
| 1.1.1.267 | Malaria |
22355528 |
Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum. |
causal interaction
therapeutic application
unassigned |
3
3
0 |
| 1.1.1.267 | Malaria |
22894148 |
The druggable antimalarial target PfDXR: overproduction strategies and kinetic characterization. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 1.1.1.267 | Malaria |
23649394 |
[Structural biology for developing antimalarial compounds]. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 1.1.1.267 | Malaria |
27650666 |
In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. |
causal interaction
ongoing research
therapeutic application
unassigned |
3
1
4
0 |
| 1.1.1.267 | Tuberculosis |
15065882 |
Kinetic and chemical mechanism of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate isomeroreductase. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
